IL1B and Alzheimer disease: Inhibits the activation of NF-κB and resulting in the reduction in pro- inflammatory cytokines TNF-α, IL-1β, and IL-6.The inhibition of iNOS and COX- 2 expression in a PA-induced AD animal model in a dose-dependent manner.